First Time Loading...

Burning Rock Biotech Ltd
NASDAQ:BNR

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
NASDAQ:BNR
Watchlist
Price: 0.8 USD Market Closed
Updated: Apr 19, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Burning Rock Biotech Ltd

Revenue
537.4m CNY
Cost of Revenue
-174.2m CNY
Gross Profit
363.2m CNY
Operating Expenses
-1B CNY
Operating Income
-669.3m CNY
Other Expenses
15.6m CNY
Net Income
-653.7m CNY

Margins Comparison
Burning Rock Biotech Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Burning Rock Biotech Ltd
NASDAQ:BNR
82.1m USD
68%
-125%
-122%
US
Abbvie Inc
NYSE:ABBV
290.8B USD
66%
30%
9%
US
Amgen Inc
NASDAQ:AMGN
140.7B USD
70%
29%
24%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
101.4B USD
87%
39%
37%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
97.8B USD
86%
32%
30%
AU
CSL Ltd
ASX:CSL
131.1B AUD
52%
26%
17%
US
Gilead Sciences Inc
NASDAQ:GILD
82.4B USD
78%
30%
21%
US
Seagen Inc
NASDAQ:SGEN
43.1B USD
75%
-33%
-33%
US
Moderna Inc
NASDAQ:MRNA
39B USD
31%
-62%
-69%
US
Biogen Inc
NASDAQ:BIIB
27.6B USD
74%
21%
12%
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD
75%
16%
12%
Country CN
Market Cap 82.1m USD
Gross Margin
68%
Operating Margin
-125%
Net Margin
-122%
Country US
Market Cap 290.8B USD
Gross Margin
66%
Operating Margin
30%
Net Margin
9%
Country US
Market Cap 140.7B USD
Gross Margin
70%
Operating Margin
29%
Net Margin
24%
Country US
Market Cap 101.4B USD
Gross Margin
87%
Operating Margin
39%
Net Margin
37%
Country US
Market Cap 97.8B USD
Gross Margin
86%
Operating Margin
32%
Net Margin
30%
Country AU
Market Cap 131.1B AUD
Gross Margin
52%
Operating Margin
26%
Net Margin
17%
Country US
Market Cap 82.4B USD
Gross Margin
78%
Operating Margin
30%
Net Margin
21%
Country US
Market Cap 43.1B USD
Gross Margin
75%
Operating Margin
-33%
Net Margin
-33%
Country US
Market Cap 39B USD
Gross Margin
31%
Operating Margin
-62%
Net Margin
-69%
Country US
Market Cap 27.6B USD
Gross Margin
74%
Operating Margin
21%
Net Margin
12%
Country IE
Market Cap 26.6B USD
Gross Margin
75%
Operating Margin
16%
Net Margin
12%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Burning Rock Biotech Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Burning Rock Biotech Ltd
NASDAQ:BNR
82.1m USD
-68%
-50%
-69%
-129%
US
Abbvie Inc
NYSE:ABBV
290.8B USD
35%
4%
16%
13%
US
Amgen Inc
NASDAQ:AMGN
140.7B USD
136%
8%
13%
11%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
101.4B USD
23%
18%
22%
44%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
97.8B USD
16%
13%
15%
32%
AU
CSL Ltd
ASX:CSL
131.1B AUD
15%
7%
11%
9%
US
Gilead Sciences Inc
NASDAQ:GILD
82.4B USD
26%
9%
16%
12%
US
Seagen Inc
NASDAQ:SGEN
43.1B USD
-28%
-21%
-27%
-39%
US
Moderna Inc
NASDAQ:MRNA
39B USD
-29%
-21%
-23%
-41%
US
Biogen Inc
NASDAQ:BIIB
27.6B USD
8%
5%
9%
8%
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD
9%
5%
7%
8%
Country CN
Market Cap 82.1m USD
ROE
-68%
ROA
-50%
ROCE
-69%
ROIC
-129%
Country US
Market Cap 290.8B USD
ROE
35%
ROA
4%
ROCE
16%
ROIC
13%
Country US
Market Cap 140.7B USD
ROE
136%
ROA
8%
ROCE
13%
ROIC
11%
Country US
Market Cap 101.4B USD
ROE
23%
ROA
18%
ROCE
22%
ROIC
44%
Country US
Market Cap 97.8B USD
ROE
16%
ROA
13%
ROCE
15%
ROIC
32%
Country AU
Market Cap 131.1B AUD
ROE
15%
ROA
7%
ROCE
11%
ROIC
9%
Country US
Market Cap 82.4B USD
ROE
26%
ROA
9%
ROCE
16%
ROIC
12%
Country US
Market Cap 43.1B USD
ROE
-28%
ROA
-21%
ROCE
-27%
ROIC
-39%
Country US
Market Cap 39B USD
ROE
-29%
ROA
-21%
ROCE
-23%
ROIC
-41%
Country US
Market Cap 27.6B USD
ROE
8%
ROA
5%
ROCE
9%
ROIC
8%
Country IE
Market Cap 26.6B USD
ROE
9%
ROA
5%
ROCE
7%
ROIC
8%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More